|
C2ORF42 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.34480000363513E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.47129999481666E-08 |
| Normal-vs-Stage2 |
5.424000E-02 |
| Normal-vs-Stage3 |
3.83860000000569E-05 |
| Normal-vs-Stage4 |
2.397600E-02 |
| Stage1-vs-Stage2 |
3.413600E-01 |
| Stage1-vs-Stage3 |
3.255400E-01 |
| Stage1-vs-Stage4 |
9.201800E-01 |
| Stage2-vs-Stage3 |
1.335400E-01 |
| Stage2-vs-Stage4 |
5.894800E-01 |
| Stage3-vs-Stage4 |
4.762000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.07889999992439E-07 |
| Normal-vs-AfricanAmerican |
3.43770000021948E-07 |
| Normal-vs-Asian |
2.902000E-01 |
| Caucasian-vs-AfricanAmerican |
2.185600E-01 |
| Caucasian-vs-Asian |
3.816400E-01 |
| AfricanAmerican-vs-Asian |
1.839610E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.71249999736389E-08 |
| Normal-vs-Female |
2.351400E-04 |
| Male-vs-Female |
3.058800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.32439999470202E-08 |
| Normal-vs-Extreme_Weight |
7.88509999516407E-08 |
| Normal-vs-Obese |
1.50654999999666E-05 |
| Normal-vs-Extreme_Obese |
3.276800E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.259800E-01 |
| Normal_Weight-vs-Obese |
1.525210E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.695600E-02 |
| Extreme_Weight-vs-Obese |
4.921200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.072800E-01 |
| Obese-vs-Extreme_Obese |
3.371000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.505700E-02 |
| Normal-vs-Age(41-60Yrs) |
6.13849999999694E-05 |
| Normal-vs-Age(61-80Yrs) |
1.62250000101949E-08 |
| Normal-vs-Age(81-100Yrs) |
7.215300E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.179400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.073600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.254800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.908100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.551900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.838400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.59699999999963E-05 |
| Normal-VS-Type2 PRCC |
1.95350002840655E-09 |
| Normal-VS-KIRP CIMP |
4.30129999999807E-05 |
| Normal-VS-Unclassified PRCC |
5.305800E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.924610E-03 |
| Type1 PRCC-VS-KIRP CIMP |
2.324000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
9.293200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.359600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
8.940200E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
2.096400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.02889999964439E-07 |
| Normal-vs-N1 |
4.164300E-03 |
| Normal-vs-N2 |
1.999490E-04 |
| N0-vs-N1 |
3.485000E-01 |
| N0-vs-N2 |
1.314170E-01 |
| N1-vs-N2 |
4.665900E-02 |
|
|
